FINWIRES · TerminalLIVE
FINWIRES

LG Electronics Introduces LG ePaper Display, to Launch in South Korea in June

By

LG Electronics (KRX:066570) introduced an ultra-low-power display on Thursday, called the LG ePaper Display, according to a same-day release.

The product is expected to launch in the domestic market in June, following which it will be introduced across the overseas markets, the release said.

The paper-like digital signage uses electronic ink technology to considerably lower power consumption while displaying menus, advertisements, and promotional content. The 32-inch display supports quad high definition (QHD) resolution, features enhanced color reproduction via LG's proprietary algorithm, and offers wide viewing angles, it said.

Shares of LG Electronics fell 4% at market close.

Related Articles

Asia

InnoCare Pharma's Orelabrutinib Gets Australia Nod to Treat Mantle Cell Lymphoma

InnoCare Pharma's (HKG:9969) orelabrutinib was approved by the Therapeutic Goods Administration (TGA) in Australia to treat adult patients with relapsed or refractory mantle cell lymphoma, according to a Thursday Hong Kong bourse filing.Orelabrutinib has been developed by the pharma firm to treat cancers and autoimmune diseases.

$HKG:9969
Asia

L&F Provides KRW30 Billion Loan to Subsidiary L&F Plus

L&F Plus took out a loan of 30 billion won from its parent and battery materials producer L&F (KRX:066970) to secure funds for new facility investment, according to a filing with the Korea Exchange on Thursday.The loan period is from May 29 to Dec. 30. The loan amount is equivalent to 4.43% of L&F Plus' total equity capital, it said.Shares of L&F added over 13% at market close.

$KRX:066970
Asia

Samsung Electronics, Harvard Medical School Affiliate MGH to Study GLP-1 Treatment Effects Using Galaxy Watch

Samsung Electronics (KRX:005930) and Harvard Medical School affiliate Massachusetts General Hospital (MGH) will jointly track and analyze physical changes in patients taking glucagon-like peptide-1 (GLP-1) class treatments with the help of the Galaxy Watch.GLP-1 is an intestinal hormone that helps regulate blood sugar and suppress appetite, Samsung Electronics said in a Thursday release.The study will assess whether data from the Galaxy Watch 8 and Samsung Health can help manage muscle loss in patients who take GLP-1 drugs by tracking body composition, activity, and heart rate, according to the release.Shares of Samsung Electronics fell over 2% at market close.

$KRX:005930